In pulmonary arterial hypertension, GLP-1 receptor agonists significantly lowered the risk of right heart failure compared ...

Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

Researchers have identified that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are widely used to control type ...

A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against ...

GLP-1 RAs are not linked to an increased risk for serious GI or hepatobiliary outcomes, compared with other diabetes medications.

GLP-RAs significantly improved liver histology, liver fat, and metabolic markers in patients with MASLD, outperforming DDP-4 inhibitors but increasing mild GI side effects.

Two newly approved medications expand options beyond lifestyle modifications for metabolic dysfunction-associated steatotic ...

Studies combing through past patient data have made a similar link between drugs like Ozempic and a loss of appetite for more than just food.

Weight loss surgery offers lasting results that go beyond reducing body weight. It helps improve diabetes control, supports ...